Search

Author/Creator Lohse, A.W.

1. Course of hepatitis C virus (HCV) RNA and HCV core antigen testing are predictors for reaching sustained virologic response in liver transplant recipients undergoing sofosbuvir treatment in a real‐life setting. Issue 1 (30th January 2016)

Authors:
Pischke, S.; Polywka, S.; Proske, V.M.; Lang, M.; Jordan, S.; Nashan, B.; Lohse, A.W.; Sterneck, M.
Journal:
Transplant infectious disease
Issue:
Volume 18:Issue 1(2016)
Page Start:
141
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Efficacy and safety of sofosbuvir/ledipasvir for the treatment of patients with hepatitis C virus re‐infection after liver transplantation. Issue 3 (10th May 2016)

Authors:
Ciesek, S.; Proske, V.; Otto, B.; Pischke, S.; Costa, R.; Lüthgehetmann, M.; Polywka, S.; Klempnauer, J.; Nashan, B.; Manns, M.P.; von Hahn, T.; Lohse, A.W.; Wedemeyer, H.; Mix, H.; Sterneck, M.
Journal:
Transplant infectious disease
Issue:
Volume 18:Issue 3(2016)
Page Start:
326
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗